Researchers at Beaumont Health will notice another way we are coming together to form a cohesive team: The Human Investigation Committee at Beaumont, Royal Oak has taken on a new name and handles all study review and approvals for the entire organization.
The new name will be Institutional Review Board, or IRB, which is more recognizable and the industry standard. “Federal regulations require all human subject research studies be reviewed by an IRB,” explains Graham Krasan, M.D., IRB chair, Beaumont Health. “The job of the IRB is to keep people safe from unethical research.”
With all three founding organizations using one IRB, it’s important for researchers to have a streamlined process to open new studies. “This is going to be a welcome change for many researchers,” says Dr. Krasan. “They’ll have eight hospitals to draw patients and data from now. We’ll also be able to offer study options to more patients in a larger geographic area.”
Beaumont Health System has more than 1,000 clinical research studies open, with 300 to 400 new studies opening each year. The team at Botsford has 34 studies, while Oakwood has about 140.
Investigators will submit proposals for their research, including chart reviews, surveys, drugs, biologics, devices, radiation, heart valves and more to the new, central IRB. If you have any questions about submitting a proposal, call the IRB at 248-551-0662.